Delisting risk
Beyond Air (XAIR)
Makes an ambient-air nitric oxide system for newborn respiratory care.
$3.61
Pre-market−0.01 (−0.22%)
At close$3.62(−1.09%)
In millions of USD, except per-share figures
| In millions | Q2 FY24Sep 2023 | Q3 FY24Dec 2023 | Q4 FY24Mar 2024 | Q1 FY25Jun 2024 | Q2 FY25Sep 2024 | Q3 FY25Dec 2024 | Q4 FY25Mar 2025 | Q1 FY26Jun 2025 | Q2 FY26Sep 2025 | Q3 FY26Dec 2025 | Q4 FY26Mar 2026 | Q1 FY27Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Cost of revenue | 0 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Gross profit | 0 | 0 | −1 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 17 | 17 | 12 | 13 | 12 | 11 | 7 | 8 | 7 | 7 | 7 | 7 | |
| Research & development | 7 | 7 | 6 | 6 | 5 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| 10 | 10 | 6 | 7 | 7 | 8 | 4 | 5 | 5 | 4 | 5 | 5 | |
| Selling & marketing | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 10 | 5 | 6 | 7 | 7 | 8 | 4 | 5 | 5 | 4 | 5 | 5 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | −18 | −17 | −13 | −14 | −13 | −11 | −7 | −8 | −8 | −7 | −7 | −7 |
| 0 | 0 | −2 | 1 | −1 | −2 | −1 | 0 | −1 | −1 | −3 | −2 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | −2 | 1 |
| Other non-operating income | −1 | −1 | 1 | −1 | 0 | 2 | 0 | 0 | 0 | 0 | 5 | 0 |
| Income before tax | −17 | −17 | −15 | −13 | −14 | −13 | −8 | −8 | −8 | −8 | −10 | −8 |
| Net income from continuing operations | −17 | −17 | −15 | −13 | −14 | −13 | −8 | −8 | −8 | −8 | −10 | −8 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −16 | −16 | −14 | −12 | −13 | −13 | −8 | −8 | −8 | −7 | −10 | −8 |
| EPS, basic | −$204.00 | −$199.80 | −$142.80 | −$106.40 | −$113.40 | −$59.20 | −$35.80 | −$30.60 | −$25.00 | −$17.00 | −$0.60 | −$11.00 |
| EPS, diluted | −$204.00 | −$199.80 | −$142.80 | −$106.40 | −$113.40 | −$59.20 | −$35.80 | −$30.60 | −$25.00 | −$17.00 | −$0.60 | −$11.00 |
| Weighted average shares, basic | — | — | — | — | — | — | — | — | — | 0 | 8 | 1 |
| Weighted average shares, diluted | — | — | — | — | — | — | — | — | — | 0 | 8 | 1 |
| EBITDA | −16 | −16 | −13 | −11 | −12 | −12 | −7 | −7 | −7 | −6 | −12 | −6 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| EBIT | −17 | −16 | −14 | −12 | −13 | −13 | −7 | −8 | −8 | −7 | −13 | −6 |
